Clinical Trial Update: Dose Dense MVAC for Muscle Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for dose-dense MVAC chemotherapy in muscle invasive bladder cancer and high-risk urothelial carcinoma of the upper urinary tract, completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High Risk Urothelial Carcinoma of the Upper Urinary Tract
• Muscle-invasive Bladder Cancer

Drugs mentioned

• MVAC (methotrexate, vinblastine, doxorubicin, cisplatin) chemotherapy regimen

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Muscle Invasive Bladder Cancer, High Risk Urothelial Carcinoma of the Upper Urinary Tracts | Phase 2 | Status: COMPLETED | Results posted: 2019-08-21